LAA-23232-59103
3 vaccinations
1 coded response
32 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 724 / AR
- Registered
- 2022-06-25
- Relationship
- Child or adolescent in my care
- Guardian
- 28A-92556-45348
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Registered in v-safe
-
2022-06-27
Dose 1 — Pfizer-BioNTech
- 2022-06-27
- 2022-06-28
-
2022-06-29
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-06-30
- 2022-07-01
- 2022-07-02
- 2022-07-04
- 2022-07-11
-
2022-07-18
Dose 2 — Pfizer-BioNTech
- 2022-07-18
- 2022-07-19
-
2022-07-20
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Fever · Irritability/crying, Loss of appetiteUnder 3 check-in
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-27
- 2022-08-01
- 2022-08-08
- 2022-08-15
- 2022-08-22
-
2022-08-29
Survey response — day 42, dose 2, under 3MedDRA: Cough, Rhinorrhoea, Sneezing — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough sneeze runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-08-29
Report sent to call center — day 42, dose 2, under 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-08-30
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-09-12
Dose 3 — Pfizer-BioNTech
- 2022-09-12
- 2022-09-16
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-28
- 2022-10-03
- 2022-10-17
- 2022-10-24
- 2022-12-12
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-27 | Pfizer-BioNTech | No |
| 2 | 2022-07-18 | Pfizer-BioNTech | No |
| 3 | 2022-09-12 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-08-29 | Successful 2022-08-30 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Cough sneeze runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release